JNJ

What’s That Smell? Another Johnson & Johnson Recall
Pharmalot
Wed, 05/11/11 - 10:35 am
JNJ
recalls
Prezista
Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk
Bloomberg
Wed, 05/11/11 - 08:47 am
Amgen
Epogen
JNJ
Procrit
anemia
Why Johnson & Johnson Is Using Stock to Buy Synthes
NY Times, NY
Wed, 05/11/11 - 08:46 am
JNJ
Synthes
M&A
Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study
Yahoo/AP
Mon, 05/9/11 - 06:48 pm
JNJ
ulcerative colitis
Remicade
J&J Files New Concerta Lawsuit Against Impax Labs
Drug Discovery & Development
Mon, 05/9/11 - 11:06 am
JNJ
Concerta
Impax
Crohn's patients respond to J&J's Stelara in study
Reuters
Mon, 05/9/11 - 09:22 am
JNJ
Stelara
Crohn's Disease
J&J, Generics Makers to Revamp Children's Tylenol Products
Motley Fool
Fri, 05/6/11 - 08:56 am
JNJ
generics
Tylenol
acetaminophen
Smith & Nephew not jealous over Synthes/JNJ union
Thu, 05/5/11 - 09:33 pm
Smith & Nephew
Synthes
JNJ
acquisitions
Johnson & Johnson CFO: Synthes deal doesn't mean we're done
Tue, 05/3/11 - 10:54 pm
Synthes
JNJ
acquisitions
Biotech Calendar: Key Dates for May
Seeking Alpha
Mon, 05/2/11 - 12:42 pm
biotech
Columbia Laboratories
KV Pharmaceutical
Dendreon
Vertex Pharmaceuticals
MannKind
Alimera
Merck
NPS Pharmaceuticals
Ironwood
BioMimetic Therapeutics
Lexicon Pharmaceuticals
Avanir
Optimer
JNJ
Johnson & Johnson / Synthes: Should the Cash Have Been Used Differently?
Seeking Alpha
Mon, 05/2/11 - 09:11 am
M&A
JNJ
Synthes
Zeltia to Miss $10 Million Yondelis Payment After U.S. Setback
Bloomberg
Sun, 05/1/11 - 04:23 pm
Zeltia
Yondelis
ovarian cancer
JNJ
Drug Companies Stocks Underperfoming: JNJ, NVS, PFE
Trader's Huddle
Sat, 04/30/11 - 11:27 am
JNJ
Novartis
Pfizer
Johnson & Johnson’s Centocor Withdraws Trabectedin Application
Bloomberg
Sat, 04/30/11 - 10:04 am
JNJ
Janssen Biotech
Trabectedin
ovarian cancer
Fitch considers J&J downgrade on buyout
Yahoo/AP
Sat, 04/30/11 - 10:03 am
JNJ
Are Top-Earning Pharma CEOs (We Mean You, William Weldon) Worth the $$$?
WSJ Online
Fri, 04/29/11 - 10:17 am
Pharma CEOs
executive pay
William Weldon
JNJ
CEO: J&J learned recall lessons, will bounce back
Fri, 04/29/11 - 04:37 am
CEO
JNJ
recalls
Johnson & Johnson Prostate Cancer Drug Approved by U.S. FDA
Bloomberg
Thu, 04/28/11 - 10:00 pm
prostate cancer
JNJ
FDA
abiraterone
Zimmer, Stryker May Seek to Buy to Keep Pace With J&J Deal
Thu, 04/28/11 - 09:23 am
Zimmer
Stryker
JNJ
acquisitions
J&J Agrees to Buy Synthes for $21.3 Billion to Gain Devices
Thu, 04/28/11 - 08:44 am
JNJ
Synthes
acquisitions

Pages